Abstract
The purpose of this study was to assess the efficacy of modafinil in combating opioid-induced sedation. A 1-year retrospective chart review of all patients receiving modafinil, a wake-promoting agent, to treat opioid-induced sedation. Opioid-induced sedation was measured using Epworth Sleepiness Scale (ESS). Outpatient, private practice. Eleven adult patients, six female and five male, being treated with opioids for chronic, nonmalignant pain. A significant decrease was observed between pretreatment and posttreatment ESS measurements during modafinil treatment. The results suggest an improvement in opioid-induced sedation in patients treated for nonmalignant pain.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
